Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS TrialKyaw Aung, Jennifer J. Knox, Mathieu Lemire et al.|Clinical Cancer Research|2017Cited by 635
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriersTalia Golan, Steven Gallinger, Zaheer Kanji et al.|British Journal of Cancer|2014Cited by 437
Germline <i>BRCA</i> Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic AdenocarcinomaSpring Holter, Steven Gallinger, Anna Dodd et al.|Journal of Clinical Oncology|2015Cited by 396
Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancerQing Chang, David W. Hedley|British Journal of Cancer|2008Cited by 155
Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenograftsPeng Cao, David W. Hedley|British Journal of Cancer|2009Cited by 124